A combination of E. coli DNA fragments and modified lipopolysaccharides as a cancer immunotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/16725239

Vaccine 2006 Jul 26 24 31-32 5862-71

Download in:

View as

Triples

General Info

PMID
16725239